Command Palette

Search for a command to run...

GKB
67(-0.48%)
1W: +0.07%

GKB Ophthalmics Peer Comparison

Snapshot Summary

GKB Ophthalmics Ltd. demonstrates moderate revenue growth but faces significant profitability challenges with negative margins and returns. Among its peers, Poly Medicure Ltd. stands out as a strong performer in profitability and growth metrics, while several companies like Nureca Ltd. and GKB itself exhibit financial weaknesses. Investors should cautiously evaluate GKB, considering its growth potential against profitability risks.

  • Poly Medicure Ltd. shows the highest revenue growth and profitability metrics, making it the sector leader.
  • GKB has negative EPS and ROE, indicating financial stress despite decent revenue growth.
  • Nureca Ltd. and GKB Ophthalmics are among the financially weak companies with poor returns.
  • Poly Medicure Ltd.: Highest revenue growth (21.37% YoY) and strong profitability metrics (ROE of 16.01%).
  • Prevest Denpro Ltd.: Good ROE and cash flow metrics with no debt, suggesting a robust financial position.
  • Laxmi Dental Ltd.: Highest ROE of 96.95% although it faces growth challenges.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
GKB₹78.98₹39.81Cr-6.52-6.32%0.28
POLYMED₹2,072.30₹20,997.79Cr63.3720.37%0.06
LAXMIDENTL₹340.30₹1,870.36Cr100.5221.79%0.99
Prevest Denpro Ltd.₹569.55₹683.63Cr37.5625.24%-
Hemant Surgical Industries Ltd.₹297.80₹310.90Cr38.24--
NURECA₹241.55₹241.55Cr-184.25-1.06%0.00
Raaj Medisafe India Ltd.₹84.59₹111.77Cr18.23--

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.